APA (7th ed.) Citation

Doshi, S., Kingston, H., Tseng, A. S., Chohan, B. H., Sambai, B., Guthrie, B. L., . . . Farquhar, C. (2023). SARS-CoV-2 antibody prevalence, correlates, and access to harm reduction services among people who inject drugs living with and without HIV and their partners in Kenya. Harm Reduction Journal, 20(1), . https://doi.org/10.1186/s12954-023-00754-5

Chicago Style (17th ed.) Citation

Doshi, Shradha, et al. "SARS-CoV-2 Antibody Prevalence, Correlates, and Access to Harm Reduction Services Among People Who Inject Drugs Living with and Without HIV and Their Partners in Kenya." Harm Reduction Journal 20, no. 1 (2023). https://doi.org/10.1186/s12954-023-00754-5.

MLA (9th ed.) Citation

Doshi, Shradha, et al. "SARS-CoV-2 Antibody Prevalence, Correlates, and Access to Harm Reduction Services Among People Who Inject Drugs Living with and Without HIV and Their Partners in Kenya." Harm Reduction Journal, vol. 20, no. 1, 2023, https://doi.org/10.1186/s12954-023-00754-5.